Delivery Order SPE2DB22D3009-SPE2DB24FAR80
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 290 MCG CAPSULE medication, with a ceiling value of $2,214.08 and a completion date of July 3, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG capsules. The contract has a ceiling value of $1,882.29 and a completion date of September 17, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The award is for the pharmaceutical product LINZESS 145 MCG CAPSULE in 30-count units, with a ceiling value of $2,635.63 and a performance period through April 5, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, specializes in providing pharmaceuticals and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of LINZESS 145 MCG capsules. The ceiling value of the contract is $3,617.28 and the ultimate completion date is November 17, 2023. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is for the supply of 4,565,166,995 units of the prescription drug LINZESS 145 MCG Capsule. The contract has a ceiling value of $2,059.67 and a period of performance ending on July 17, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds several...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the prescription medication LINZESS 72 MCG CAPSULE UU 30S. The firm-fixed-price contract has a ceiling value of $7,590.99 and a completion date of July 2, 2025. It is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LINZESS 72 MCG CAPSULE UU 30S. The contract has a ceiling value of $1,929.45 and a completion date of May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LINZESS 290 MCG CAPSULE UU 30S, a medication, with a ceiling value of $1,200.81. The contract is a firm fixed price, non-set-aside contract with a performance period ending on May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LINZESS 72 MCG CAPSULE medical products, with a ceiling value of $1,624.42 and a period of performance through May 9, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG CAPSULE UU 30S medication. The contract has a ceiling value of $1,543.27 and a completion date of November 4, 2024. It is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB24FAR80Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 145 mcg LINZESS capsules, a prescription medication. The contract has a ceiling value of $1,841.60 and a period of performance through March 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary contract vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was not set aside for any particular business category.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/11/24 |